Advertisement

Use of Alternative Medicine by Patients With Stage 5 Chronic Kidney Disease

  • Jerrilynn D. Burrowes
    Correspondence
    Address correspondence to Jerrilynn D. Burrowes, PhD, RD, C.W. Post Campus of Long Island University, School of Health Professions and Nursing, Department of Nutrition, 720 Northern Blvd, Brookville, NY 11548.
    Affiliations
    C.W. Post Campus of Long Island University, School of Health Professions and Nursing, Department of Nutrition, Brookville, NY
    Search for articles by this author
  • Gloria Van Houten
    Affiliations
    St. Catherine of Siena Medical Center, The Center for Renal Disease, Smithtown, NY
    Search for articles by this author
      The use of complementary and alternative medicine (CAM) in the United States is growing at a remarkable speed. Herbal products and dietary supplements are CAM therapies that have grown faster than any other CAM treatments. Little information is available about herbs and dietary supplement use in the stage 5 chronic kidney disease population. These products contain a myriad of pharmacologically active compounds that, when used by people with kidney disease, may be hazardous. Members of the renal dietitian listserv were queried about herbs and dietary supplements reportedly used by dialysis patients. Up-to-date information on the use, safety, efficacy, adverse effects, and recommended dosages in the nondialysis population are presented for 24 products. In the dialysis population, Noni juice should be avoided because of its high potassium content. In addition, bulk-forming laxatives such as flaxseed should be used with caution because of the need for increased fluid intake. Dialysis practitioners should include specific questions about herbs and dietary supplement use in medical and nutrition histories, and they should increase their knowledge about these products to advise patients appropriately. A list of reliable sources of information for the health care provider on herbs and dietary supplements is also presented.

      Index Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Advances in Chronic Kidney Disease
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Institute of Medicine of the National Academies: Complementary and alternative medicine (CAM) in the United States. Available at: http://www.nap.edu/books/0309092701/html. Accessed January 23, 2005.

        • Barnes P.M.
        • Powell-Griner E.
        • McFann K.
        • et al.
        Complementary and Alternative Medicine Use Among Adults: United States, 2002. Advance Data From Vital and Health Statistics no 343. National Center for Health Statistics, Hyattsville, MD2004
        • Fragakis A.S.
        The Health Professional’s Guide to Popular Dietary Supplements. (ed 2). American Dietetic Association, Chicago, IL2003
      2. White House Commission on Complementary and Alternative Medicine Policy. Final Report: White House Commission on complementary and alternative medicine policy. 2002 (Washington, DC)
        • Eisenberg D.M.
        • Davis R.B.
        • Ettner S.L.
        • et al.
        Trends in alternative medicine use in the United States, 1990–1997.
        JAMA. 1998; 280: 1569-1575
        • Slesinski M.J.
        • Subar A.F.
        • Kahle L.L.
        Trends in use of vitamin and mineral supplements in the Unites States.
        J Am Diet Assoc. 1995; 95: 921-923
        • Druss B.G.
        • Rosenbeck R.A.
        Association between use of unconventional therapies and conventional medical services.
        JAMA. 1999; 282: 651-656
        • Astin J.A.
        Why patients use alternative medicine.
        JAMA. 1998; 279 (1548–1543)
      3. Food and Drug Administration: Dietary Supplement Health and Education Act of 1994. Available at: http://vm.cfsan.fda.gov/∼dms/dietsuppl.html. Accessed January 23, 2005.

        • Kleshinski F.G.
        • Crews C.
        • Fry E.
        • et al.
        A survey of herbal product use in a dialysis population in northwest Ohio.
        J Renal Nutr. 2003; 13: 93-97
        • Dahl N.V.
        Herbs and supplements in dialysis patients.
        Semin Dial. 2001; 14: 186-192
        • Chow J.
        Probiotics and prebiotics.
        J Renal Nutr. 2002; 12: 76-86
        • Jellin J.M.
        • Gregory P.J.
        • Batz F.
        • et al.
        Pharmacist’s Letter/Prescriber’s Letter Natural Medicines Comprehensive Database. (ed 4). Therapeutic Research Faculty, Stockton, CA2002: 131-1384
        • Simenhoff M.L.
        • Dunn S.R.
        • Zoliner G.P.
        • et al.
        Biomodulation of the toxic and nutritional effects of small bowel bacterial overgrowth in end-stage kidney disease using freeze-dried Lactobacillus acidophilus.
        Miner Electro Metab. 1996; 22: 92-96
        • Hida M.
        • Aiba Y.
        • Sawamura S.
        • et al.
        Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin, a lactic acid bacterial preparation, to uremic patients undergoing hemodialysis.
        Nephron. 1996; 74: 349-355
        • Liske E.
        • Hanggi W.
        • Henneicke-von Zepelin H.H.
        • et al.
        Physiological investigation of a unique extract of black cohosh (Cimicifugae racemosae rhizome).
        J Womens Health Gend Based Med. 2002; 11: 163-174
        • Khan A.
        • Safdar M.
        • Ali Khan M.M.
        • et al.
        Cinnamon improves glucose and lipids of people with type 2 diabetes.
        Diabetes Care. 2003; 26: 3215-3218
        • Leeb B.F.
        • Schweitzer H.
        • Montag K.
        • et al.
        A meta-analysis of chondroitin sulfate in the treatment of arthritis.
        J Rheumatol. 2000; 27: 205-211
        • McAlindon T.E.
        • LaValley M.P.
        • Gulin J.P.
        • et al.
        Glucosamine and chondroitin for treatment of osteoarthritis.
        JAMA. 2000; 283: 1469-1475
        • Uebellhart D.
        • Malaise M.
        • Marcologo R.
        • et al.
        Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate.
        Osteoarth Cartil. 2004; 12: 269-276
        • Folkers K.
        • Langsjoen P.
        • Willis R.
        • et al.
        Lovastatin decreases coenzyme Q levels in humans.
        Proc Natl Acad Sci U S A. 1990; 87: 8931-8934
        • Brinkeborn R.M.
        • Shah D.V.
        • Degenring F.H.
        Echinaforce and other echinacea fresh plant preparations in the treatment of the common cold. A randomized, placebo controlled double-blind clinical trial.
        Phytomedicine. 1999; 6: 1-6
        • Giles J.T.
        • Palat C.T.
        • Chien S.H.
        • et al.
        Evaluation of Echinacea for treatment of the common cold.
        Pharmacotherapy. 2000; 20: 690-697
        • Grimm W.
        • Muller H.H.
        A randomized controlled trial of the effect of fluid extract of Echinacea purpurea on the incidence and severity of colds and respiratory infections.
        Am J Med. 1999; 106: 138-143
        • Ernst E.
        The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John’s Wort, ginseng, echinacea, saw palmetto, and kava.
        Ann Intern Med. 2002; 136: 42-53
        • Melchart D.
        • Linde K.
        • Worku R.
        • et al.
        Immunomodulation with Echinacea—A systematic review of controlled clinical trials.
        Phytomedicine. 1994; 1: 245-254
        • Hsu H.C.
        • Lee Y.T.
        • Chen M.F.
        Effect of n-3 fatty acids on the composition and binding properties of lipoproteins in hypertriglyceridemic patients.
        Am J Clin Nutr. 2000; 71: 28-35
        • Roche H.M.
        • Gibney M.J.
        Effect of long-chain n-3 polyunsaturated fatty acids on fasting and postprandial triaclyglycerol metabolism.
        Am J Clin Nutr. 2000; 71: 228S-231S
        • Santos J.
        • Queiros J.
        • Silva F.
        • et al.
        Effects of fish oil in cyclosporine-treated renal transplant recipients.
        Transplant Proc. 2000; 32: 2605-2608
        • Schmitz P.
        • McCloud L.
        • Reikes S.
        • et al.
        Prophylaxis of hemodialysis graft thrombosis with fish oil.
        J Am Soc Nephrol. 2002; 13: 184-190
        • Vergili-Nelsen J.M.
        Benefits of fish oil supplementation for hemodialysis patients.
        J Am Diet Assoc. 2003; 103: 1174-1177
        • Morris M.C.
        • Sacks F.
        • Rosner B.
        Does fish oil lower blood pressure? A meta-analysis of controlled trials.
        Circulation. 1993; 88: 523-533
        • Toft I.
        • Bonaa H.
        • Ingebretsen O.C.
        • et al.
        Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. A randomized, controlled trial.
        Ann Intern Med. 1995; 123: 911-918
        • Sacks F.M.
        • Hebert P.
        • Appel L.J.
        • et al.
        The effect of fish oil on blood pressure and high-density lipoprotein-cholesterol levels in phase I of the Trials of Hypertension Prevention.
        J Hypertens. 1994; 12: 209-213
        • Vondongen R.
        • Mori T.A.
        • Burke V.
        • et al.
        Effects on blood pressure of omega 3 fats in subjects at increased risk of cardiovascular disease.
        Hypertension. 1993; 22: 371-379
        • Zhao G.
        • Etherton T.D.
        • Martin K.R.
        • et al.
        Dietary α-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women.
        J Nutr. 2004; 134: 2991-2997
        • Stevinson C.
        • Pittler M.H.
        • Ernst E.
        Garlic for treating hypercholesterolemia.
        Ann Int Med. 2000; 133: 420-429
        • Warshafsky S.
        • Kamer R.R.
        • Sivak S.L.
        Effect of garlic on total serum cholesterol.
        Ann Intern Med. 1993; 119: 599-605
        • Kannar D.
        • Wattanapenpaiboon N.
        • Savige G.S.
        • et al.
        Hypocholesterolemic effect of an enteric-coated garlic supplement.
        J Am Coll Nutr. 2001; 20: 225-231
        • Neil H.A.
        • Silagy C.A.
        • Lancaster T.
        • et al.
        Garlic powder in the treatment of moderate hypelipidemia.
        J R College Physicians Lond. 1996; 30: 329-334
        • Berthold H.K.
        • Sudhop T.
        • von Bergmann K.
        Effect of a garlic oil preparation on serum lipoproteins and cholesterol metabolism.
        JAMA. 1998; 279: 1900-1902
        • Silagy C.A.
        • Neil H.A.
        A meta-analysis of the effect of garlic on blood pressure.
        J Hypertens. 1994; 12: 463-468
        • Oken B.S.
        • Storzbach D.M.
        • Kaye J.A.
        The efficacy of Gingko biloba on cognitive function in Alzheimer disease.
        Arch Neurol. 1998; 55: 1409-1415
        • Vuksan V.
        • Sievenpiper J.L.
        • Koo V.Y.Y.
        • et al.
        American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus.
        Arch Intern Med. 2000; 160: 1009-1013
        • Wesnes K.A.
        • Ward T.
        • McGinty A.
        • et al.
        The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers.
        Psychopharmacology. 2000; 152: 353-361
        • D’Angelo L.
        • Grimaldi R.
        • Caravaggi M.
        • et al.
        A double-blind, placebo-controlled clinical study on the effect of a standardized ginseng extract on psychomotor performance in healthy volunteers.
        J Ethnopharmacol. 1986; 16: 15-22
        • Bushman J.L.
        Green tea and cancer in humans.
        Nutr Cancer. 1998; 31: 151-159
        • Fujiki H.
        • Suganuma M.
        • Okabe S.
        • et al.
        Mechanistic findings of green tea as cancer preventive for humans.
        Proc Soc Exp Bio Med. 1999; 220: 225-228
        • Pisters K.M.
        • Newman R.A.
        • Coldman B.
        • et al.
        Phase I trial of oral green tea extract in adult patients with solid tumors.
        J Clin Oncol. 2001; 19: 1830-1838
        • Serra A.
        • Uehlinger D.E.
        • Ferrari P.
        • et al.
        Gycyrrhetinic acid decreases plasma potassium concentrations in patients with anuria.
        J Am Soc Nephrol. 2002; 13: 191-196
        • Hinoshita F.
        • Ogura Y.
        • Suziku Y.
        • et al.
        Effect of orally administered Shao-Yao-Gan-Cao-Tang (Shakuyaku-kanzo-to) on muscle cramps in maintenance hemodialysis patients.
        Am J Chin Med. 2003; 31: 445-453
        • Brown L.
        • Rimm E.B.
        • Seddon J.M.
        • et al.
        A prospective study of carotenoid intake and risk of cataract extraction in U.S. men.
        Am J Clin Nutr. 1999; 70: 517-524
        • Chassan-Taber L.
        • Willet W.C.
        • Seddon J.M.
        • et al.
        A prospective study of carotenoid and vitamin A intake and risk of cataract extraction in U.S. women.
        Am J Clin Nutr. 1999; 70: 509-516
      4. University of Maryland Medical Center/Complementary Medicine: Milk thistle. Available at: http://www.umm.edu/altmed/ConsHerbs/MilkThistlech.html. Accessed January 25, 2005.

        • Mueller B.A.
        • Scott M.K.
        • Sowinski M.
        • et al.
        Noni juice (Morinda citrifolia).
        Am J Kidney Dis. 2000; 35: 310-312
        • Marks L.S.
        • Partin A.W.
        • Epstein J.L.
        • et al.
        Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hypertrophy.
        J Urol. 2000; 163: 1451-1456
        • Linde K.
        • Ramirez G.
        • Mulrow C.D.
        St. John’s wort for depression: An overview and meta-analysis of randomized clinical trials.
        BMJ. 1996; 313: 253-258
        • Kim H.L.
        • Streltzer J.
        • Goebert D.
        St. John’s wort for depression: A meta-analysis of well-defined clinical trials.
        J Nerv Ment Dis. 1999; 187: 532-539
        • Schrader E.
        Equivalence of St. John’s wort extract (Ze 117) and fluoxetine: A randomized, controlled study in mild-moderate depression.
        Int Clin Psychopharmacol. 2000; 15: 61-68
        • Beckman S.E.
        • Sommi R.W.
        • Switzer J.
        Consumer use of St. John’s wort: A survey on effectiveness, safety, and tolerability.
        Pharmacotherapy. 2000; 20: 568-574
        • Dean A.J.
        • Moses G.M.
        • Vernon J.M.
        Suspected withdrawal syndrome after cessation of St Johns Wort.
        Ann Pharmacother. 2003; 37: 150
        • Mai I.
        • Kruger H.
        • Budde K.
        • et al.
        Hazardous pharamacokinetic interaction of St. John’s wort (Hypericum perforatum) with the immunosuppressant cyclosporin.
        Int J Clin Pharmacol Ther. 2000; 38: 500-502
        • Barone G.W.
        • Gurley B.J.
        • Ketel B.L.
        • et al.
        Drug interaction between St. John’s wort and cyclosporine.
        Ann Pharmacother. 2000; 34: 1014-1016
        • Duncan M.G.
        The effects of nutritional supplements on the treatment of depression, diabetes, and hypercholesterolemia in the renal patient.
        J Renal Nutr. 1999; 9: 58-62
        • Fishbane S.
        • Frei G.L.
        • Finger M.
        • et al.
        Hypervitaminosis A in two hemodialysis patients.
        Am J Kidney Dis. 1995; 25: 346-349
      5. Farley D: Dietary supplements: making sure hype doesn’t overwhelm science. Available at: http://www.fda.gov/bbs/topics/consumer/con00259.html. Accessed December 10, 2004.

      6. Food and Drug Administration: Illnesses and injuries associated with the use of selected dietary supplements. Available at: http://www.cfsan.fda.gov/∼dms/ds-ill.html. Accessed December 10, 2004.

        • Age-Related Eye Disease Study Research Group
        A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.
        Arch Ophthamol. 2001; 119: 1417-1436
        • Tardif J.C.
        • Cote G.
        • Lesperance J.
        • et al.
        Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group.
        N Engl J Med. 1997; 337: 365-372
        • Brown B.G.
        • Zhao X.Q.
        • Chait A.
        • et al.
        Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease.
        N Engl J Med. 2001; 345: 1583-1592
        • Tremblay R.
        • Bonnardeaux A.
        • Geadah D.
        • et al.
        Hyperhomocysteinemia in hemodialysis patients.
        Kidney Int. 2000; 58: 851-858
        • McKinley M.C.
        • McNulty H.
        • McPartlin J.
        • et al.
        Low-dose vitamin B-6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete.
        Am J Clin Nutr. 2001; 73: 759-764
        • Dierkes J.
        • Domrose U.
        • Bosselmann K.P.
        • et al.
        Homocysteine lowering effect of different multivitamin preparations in patients with end-stage renal disease.
        J Renal Nutr. 2001; 11: 67-72
        • Okada H.
        • Moriwaki K.
        • Kanno Y.
        • et al.
        Vitamin B6 supplementation can improve peripheral polyneuropathy in patients with chronic renal failure on high-flux haemodialysis and human recombinant erythropoietin.
        Nephrol Dial Transplant. 2000; 15: 1410-1413
        • Baxmann A.C.
        • Mendonca C.O.G.
        • Heilberg I.P.
        Effect of vitamin C supplements on urinary oxalate and pH in calcium stone-forming patients.
        Kidney Int. 2003; 63: 1066-1071
        • Curhan G.C.
        • Willett W.C.
        • Speizer F.E.
        • et al.
        Intake of vitamins B6 and C and the risk of kidney stones in women.
        J Am Soc Nephrol. 1999; 10: 840-845
        • Keven K.
        • Kutlay S.
        • Nergizoglu G.
        • et al.
        Randomized, crossover study of the effect of vitamin C on EPO response in hemodialysis patients.
        Am J Kidney Dis. 2003; 41: 1233-1239
        • Hegbrant J.
        • Hultkvist Bengtsson U.
        Vitamin C and E as antioxidants in hemodialysis patients.
        Int J Artif Organs. 1999; 22: 69-73
        • Boeschoten E.W.
        • Schrijver J.
        • Krediet R.T.
        • et al.
        Deficiencies of vitamins in CAPD patients.
        Nephrol Dial Transplant. 1988; 3: 187-193
        • Descombes E.
        • Hanck A.B.
        • Fellay G.
        Water soluble vitamins in chronic hemodialysis patients and need for supplementation.
        Kidney Int. 1993; 43: 1319-1328
        • Rocco M.V.
        • Makoff R.
        Appropriate vitamin therapy for dialysis patients.
        Semin Dial. 1997; 10: 272-277
        • Cristol J.P.
        • Bosc J.Y.
        • Badiou S.
        • et al.
        Erythropoietin and oxidative stress in haemodialysis.
        Nephrol Dial Transplant. 1997; 12: 2312-2317
        • Boaz M.
        • Simetana S.
        • Weinstein T.
        • et al.
        Secondary prevention with antioxidants of cardiovascular disease in end stage renal disease (SPACE).
        Lancet. 2000; 356: 1213-1218
        • Miller E.R.
        • Pastor-Barriuso R.
        • Dalal D.
        • et al.
        Meta-analysis.
        Ann Intern Med. 2005; 142: 37-46
        • Mahajan S.K.
        • Prasad A.S.
        • Lambujon J.
        • et al.
        Improvement of uremic hypogeusia by zinc.
        Am J Clin Nutr. 1980; 33 (1571–1521)
        • Matson A.
        • Wright M.
        • Oliver A.
        • et al.
        Zinc supplementation at conventional doses does not improve the disturbance of taste perception in hemodialysis patients.
        J Renal Nutr. 2003; 13: 224-228
        • Grabe D.W.
        • Garrison G.D.
        Comparison of natural product use between primary care and nephrology patients.
        Ann Pharmacother. 2004; 38: 1169-1172
        • Eisenberg D.M.
        Advising patients who seek alternative medical therapies.
        Ann Intern Med. 1997; 127: 61-69